Parkinson Disease Clinical Trials in Seattle, Washington

4 studies are recruiting for parkinson disease in Seattle, Washington right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. A Study to Determine if BHV-8000 is Effective, Safe and Tolerable as a Treatment for Adults Living With Early Parkinson's Disease

    A study to determine if BHV-8000 is efficacious, safe and tolerable in adults diagnosed with early Parkinson's disease. The study will consist of a 48-week double-blind treatment phase followed by a 48-week open-label phase.

    Stage
    Phase 2
    Ages
    40 to 80
    Site
    Site-019, Seattle, Washington
    Locations
    22 in total
    Run by
    Biohaven Therapeutics Ltd.

    See if you can join NCT06976268 on ClinicalTrials.gov

  2. Deep Brain Stimulation (DBS) Retrospective Outcomes Study

    The primary objective of this study is to characterize real-world clinical outcomes of Deep Brain Stimulation (DBS) using retrospective review of de-identified patient records.

    Stage
    Not phased
    Ages
    Any age
    Site
    Swedish Neuroscience Institute, Seattle, Washington
    Locations
    20 in total
    Run by
    Boston Scientific Corporation

    See if you can join NCT03664609 on ClinicalTrials.gov

  3. PPMI Clinical - Establishing a Deeply Phenotyped PD Cohort

    The Parkinson Progression Marker Initiative (PPMI) is a longitudinal, observational, multi-center natural history study to assess progression of clinical features, digital outcomes, and imaging, biologic and genetic markers of Parkinson's disease (PD) progression in study participants with manifest…

    Stage
    Not phased
    Ages
    30 and older
    Site
    Univ of Washington and VA Puget Sound Health Care System, Seattle, Washington
    Locations
    50 in total
    Run by
    Michael J. Fox Foundation for Parkinson's Research

    See if you can join NCT04477785 on ClinicalTrials.gov

  4. Use of CereGate Therapy for Freezing of Gait in PD

    A Multi-Center, Controlled Study to Evaluate Use of CereGate Therapy to Reduce Freezing of Gait in Participants Diagnosed with Parkinson's Disease.

    Stage
    Not phased
    Ages
    21 to 80
    Site
    University of Washington, Seattle, Washington
    Locations
    7 in total
    Run by
    CereGate Inc.

    See if you can join NCT05292794 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.